3rd Quarter - Report

CAPITOL COUNSEL LLC for MERCK & COMPANY, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Diabetes Prevention & Treatment, including related provisions of HR 2651, The Eliminating Disparities in Diabetes Prevention, Access and Care Act of 2013 and HR 1192, The National Diabetes Clinical Care Commission Act.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2651 (114th), H.R. 1192 (114th)

Copyright/Patent/Trademark CPT

Pharmaceutical patent issues, including related provisions in H.R. 9, the Innovation Act, and S. 1137, the PATENT Act.

LobbyistCovered position, as disclosed
AARON COHEN Chief of Staff & Legislative Assistant, Sen. John Ensign; Legislative Aide, Sen. Richard Bryan; Legislative Correspondent, Sen. Richard Bryan
SHANNON FINLEY —
CHARLES TOWNER FRENCH Staff, House Committee on Rules; Chief of Staff, Rep. Pete Sessions; Staff, House Committee on Homeland Security; Staff, Rep. Lincoln Diaz-Balart; Staff, Rep. Judy Biggert
DREW GOESL Chief of Staff, Rep. Mike Ross; Communications Director, Sen. Blanche Lincoln
MARTIN B. GOLD Floor Advisor & Counsel, Senate Majority Leader Bill Frist
LUKE HATZIS LD & LA, Cong. Peter Roskam; Republican Clerk, House Rules Committee; Legislative Aide, House Republican Conference; Floor Assistant, Speaker J. Dennis Hastert
DENISE HENRY MORRISEY —
JAMES O MCCRERY Former Member of Congress, Louisiana 4th; Ranking Member, House Ways and Means Committee; Committee Member, Joint Committee on Taxation
BRADLEY MOLLET Staff & Research Assistant, Sen. Tim Johnson; Legislative Assistant, Cong. Jim Matheson, Legislative Director, Congw. Betsy Markey
JOHN D RAFFAELLI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 9 (114th), S. 1137 (114th)

Medicare/Medicaid MMM

Medicare Coverage and Reimbursement issues; Medicare access to DXA services; Medicare reimbursement for antimicrobial drugs, including related provisions in HR 512, The Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2014.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 512 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.